Genetic Markers Predict Primary Non-Response and Durable Response to Anti-TNF Biologic Therapies in Crohn’s Disease
American Journal of Gastroenterology - United States
doi 10.1038/ajg.2016.408
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)